Holen Sie sich die Stockscreener-App
363.77
6.89%
-26.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$390.74
Offen:
$354.35
24-Stunden-Volumen:
2.37M
Relative Volume:
1.62
Marktkapitalisierung:
$80.70B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
12.51
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-14.01%
1M Leistung:
-6.03%
6M Leistung:
-24.02%
1J Leistung:
-4.37%
1-Tages-Spanne:
$353.99
$372.93
1-Wochen-Bereich:
$353.99
$418.88
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
363.77 | 86.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.30 | 16.78B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
233.84 | 15.12B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.25 | 13.13B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
106.69 | 10.92B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare Trims 2026 Profit Outlook, Stock Falls - Benzinga
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook - Barron's
HCA Healthcare Shares Drop After Quarterly Earnings Squeezed by Payer Mix Shifts - WSJ
HCA Healthcare lowers FY26 EPS guidance on payer mix shift - scanx.trade
Why Did HCA Healthcare (NYSE:HCA) Revise FY26 Projections? - Kalkine Media
HCA cuts annual profit forecast on increased uncompensated care - Reuters
Why Are HCA Healthcare (NYSE:HCA) Results Catching S&P 500 Eyes? - Kalkine Media
HCA Healthcare Expects Q2 Adjusted Earnings, Revenue to Rise; Updates 2026 Guidance - marketscreener.com
KeyCorp Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare (NYSE:HCA) Releases Q2 2026 Earnings Guidance - MarketBeat
Is HCA Undervalued? DCF Says Worth $765 - GuruFocus
HCA Healthcare lowers 2026 guidance on insurance coverage losses - Investing.com
HCA reports preliminary quarterly revenue above expectations - marketscreener.com
(HCA) HCA Healthcare Expects 2026 Revenue Range $77B$79.5B, vs. FactSet Est of $78.60B - marketscreener.com
(HCA) HCA Healthcare Expects Q2 Revenue $20.23B, vs. FactSet Est of $19.47B - marketscreener.com
BRIEF-HCA Healthcare Q2 Revenue USD 10 Million Vs. IBES Estimate USD 19,426 Million - TradingView
HCA Healthcare Previews Second Quarter 2026 Results - Business Wire
Arbejdsmarkedets Tillaegspension Purchases 4,550 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare stock reflects steady hospital demand as investors weigh long-term growth - ad-hoc-news.de
HCA Healthcare Inc (HCA) Shares Fall 3.9% -- What GF Score of 87 Tells Investors - GuruFocus
Wells Fargo Adjusts Price Target on HCA Healthcare to $428 From $436, Maintains Equalweight Rating - Moomoo
What Makes HCA Healthcare (HCA) a Compelling Investment Bet? - Yahoo Finance
HCA Healthcare (NYSE:HCA): What Comes After the Reset? - Kalkine Media
HCA Maintained by Wells Fargo -- Price Target Lowered to $428 - GuruFocus
HCA Healthcare (NYSE:HCA) Given New $428.00 Price Target at Wells Fargo & Company - MarketBeat
Wells Fargo Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $428 - Moomoo
HCA Healthcare, Inc. $HCA Shares Purchased by Teachers Retirement System of The State of Kentucky - MarketBeat
HCA Healthcare stock reflects a resilient hospital operator amid evolving US care demand - Ad Hoc News
AMF Tjanstepension AB Grows Stake in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Holdings Raised by LGT Fund Management Co Ltd. - MarketBeat
Candriam S.C.A. Sells 10,738 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare stock holds steady as hospital operator focuses on patient volumes and cost control - ad-hoc-news.de
RBC Capital Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $534 - Moomoo
HCA Florida Palms West Hospital Tops Off Expansion In Loxahatchee, Florida - Healthcare Design Magazine
HCA stock reflects steady US hospital demand as investors weigh long-term healthcare trends - ad-hoc-news.de
Enterprise value to EBIT forward of HCA Healthcare Inc – XETR:2BH - TradingView
HCA Healthcare stock reflects a major US hospital operator navigating long-term demand - ad-hoc-news.de
HCA Healthcare, Inc. $HCA Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
HCA Healthcare stock steadies as investors weigh hospital demand and expansion plans - ad-hoc-news.de
Stephens Adjusts Price Target on HCA Healthcare to $500 From $530 - marketscreener.com
Isthmus Partners LLC Sells 3,454 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare (HCA) Gets a Buy from Bank of America Securities - The Globe and Mail
HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
The Premium On HCA Healthcare Keeps Growing. So Does The Case For Universal Health - Trefis
HCA Healthcare (HCA) Could Be 35% Undervalued Following Downgrades And Index Exits - Yahoo Finance
HCA Healthcare Stock And 2 More Names Facing The Next US Immigration Test - simplywall.st
HCA Healthcare (HCA) Publishes Gene Editing Research For Children With Severe Blood Disorders - Yahoo Finance
HCA Healthcare (NYSE:HCA) Expansion Draws Healthcare Market Attention - Kalkine Media
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare Shares Fall After Barclays Downgrade - marketscreener.com
Is the Options Market Predicting a Spike in HCA Healthcare Stock? - Zacks Investment Research
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):